Vuralli, Doga
Wattiez, Anne-Sophie
Russo, Andrew F.
Bolay, Hayrunnisa
Funding for this research was provided by:
Foundation for the National Institutes of Health (NS075599)
U.S. Department of Veterans Affairs (1I01RX002101)
U.S. Department of Defense (W81XWH-16-1-0071, W81XWH-16-1-0211)
Article History
Received: 22 November 2018
Accepted: 16 January 2019
First Online: 31 January 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AFR is a consultant to Alder BioPharmaceuticals, Pharmnovo, Amgen/Novartis, and Eli Lilly.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.